Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias
Open Access
- 20 July 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 20 (9), 1572-1581
- https://doi.org/10.1038/sj.leu.2404317
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Evasion of the p53 tumour surveillance network by tumour-derived MYC mutantsNature, 2005
- Differing Roles of Akt and Serum- and Glucocorticoid-regulated Kinase in Glucose Metabolism, DNA Synthesis, and Oncogenic ActivityPublished by Elsevier BV ,2003
- Brusatol-mediated induction of leukemic cell differentiation and G1 arrest is associated with down-regulation of c-mycLeukemia, 2002
- c-MYC: more than just a matter of life and deathNature Reviews Cancer, 2002
- MYC oncogenes and human neoplastic diseaseOncogene, 1999
- Functional Analysis of Burkitt's Lymphoma Mutant c-Myc ProteinsPublished by Elsevier BV ,1996
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995
- A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.Genes & Development, 1993
- New light on Myc and Myb. Part I. Myc.Genes & Development, 1990
- Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiationNature, 1986